Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and

Dali Yin1, Norihiko Tamaki, Andrew D Parent

  • 1Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Neurological Research
|April 15, 2005
PubMed
Abstract

Insights

Insulin-like growth factor-I (IGF-I) prevents etoposide-induced apoptosis in glioma cells by upregulating bcl-2 and downregulating CPP32 activity. Blocking IGF-I receptors enhances etoposide

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Chemotherapy resistance in glioma cells is a significant challenge in cancer treatment.
  • Understanding the mechanisms underlying glioma chemoresistance is crucial for developing effective therapies.
  • The role of insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) in glioma apoptosis is not fully elucidated.

Purpose of the Study:

  • To investigate the role of IGF-I and IGF-IR in the apoptotic response of glioma cells to etoposide.
  • To elucidate the molecular mechanisms by which IGF-I influences etoposide-induced apoptosis in glioma.
  • To determine if targeting IGF-IR can overcome chemoresistance in malignant gliomas.

Main Methods:

  • Utilized two human glioma cell lines (U-87MG and KNS-42).
  • Assessed etoposide-induced cell growth inhibition using MTT assays.
  • Evaluated apoptosis via Hoechst staining, DNA fragmentation, and Western blotting.
  • Measured caspase-3 (CPP32) and ICE protease activity using ApoAlert caspase assays.
  • Investigated the effect of IGF-IR antisense on etoposide-treated glioma cells.

Main Results:

  • Etoposide inhibited glioma cell growth and induced apoptosis, increasing wild-type p53 and CPP32 activity.
  • IGF-I significantly reduced etoposide-induced apoptosis by upregulating bcl-2 expression and decreasing CPP32 activity.
  • IGF-IR antisense treatment potentiated the apoptotic effects of etoposide in both cell lines.

Conclusions:

  • IGF-I confers chemoresistance to etoposide in glioma cells through bcl-2 and CPP32 modulation.
  • Inhibition of IGF-IR signaling enhances etoposide-induced apoptosis, suggesting a therapeutic target.
  • The anti-apoptotic effects of IGF-I and IGF-IR are implicated in the chemoresistance of gliomas.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...